During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.

Controversies & Advances in the Treatment of Cardiovascular Disease, the Twenty-First in the Series

To move forward in artificial intelligence, it is critical for the medical community to learn to look at solutions in multiple ways to develop a deeper sense of duality

The 2023 AIMed Global Summit focused on artificial intelligence (AI) in healthcare, and offered valuable insights into the latest use cases, perspectives and novel approaches in healthcare AI. The event took place June 4-7 at the San Diego Convention Center in San Diego, Calif.

July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation.

The first patent (US11,684,542) is for CPR devices that use more than one type of compression pattern to increase blood flow on both sides of the heart.

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study investigators, Dr.

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD).

July 11, 2023 — Hyperfine, Inc., the groundbreaking medical device company that created the Swoop system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR).

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces that the first patient has been enrolled in its MOJAVE study.

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now